Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
89 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06635278 | Mindfulness Meditation: Alleviating Symptoms and Inflammation in Nurses | active not recruiting | N/A | 102 | Jordan University of Science and TechnologyOTHER | 1 | Oct 10, 2024 | clinicaltrials |
| NCT03447769 | Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A(Canopy-A) | terminated | Phase 3 | 1,382 | Novartis PharmaceuticalsINDUSTRY |
| 41 |
| Oct 9, 2024 |
| clinicaltrials |
| NCT03839823 | Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer(RIGHT Choice) | completed | Phase 2 | 222 | Novartis PharmaceuticalsINDUSTRY | 13 | Oct 9, 2024 | clinicaltrials |
| NCT06499103 | Effect of Transcutaneous Electrical Nerve Stimulation on CIPN Symptoms | completed | N/A | 44 | Jordan University of Science and TechnologyOTHER | 1 | Jul 17, 2024 | clinicaltrials |
| NCT04780464 | A 3 Arm Randomized Study on Health-related QoL of Elderly Patients With Advanced Soft Tissue Sarcoma(Tolerance) | terminated | Phase 3 | 14 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 2 | Feb 22, 2024 | clinicaltrials |
| NCT03503630 | Short-course Radiation Followed by mFOLFOX-6 Plus COMPOUND 2055269 for Locally-advanced Rectal Adenocarcinoma | unknown | Phase 2 | 44 | Ali ShamseddineOTHER | 2 | Jan 31, 2024 | clinicaltrials |
| NCT03674112 | A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer(PHranceSCa) | completed | Phase 2 | 160 | Hoffmann-La RocheINDUSTRY | 17 | Jan 2, 2024 | clinicaltrials |
| NCT02422615 | Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer.(MONALEESA-3) | completed | Phase 3 | 726 | Novartis PharmaceuticalsINDUSTRY | 30 | Nov 30, 2023 | clinicaltrials |
| NCT02941926 | Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC(COMPLEEMENT-1) | completed | Phase 3 | 3,246 | Novartis PharmaceuticalsINDUSTRY | 38 | Oct 24, 2023 | clinicaltrials |
| NCT06074757 | Open Label, Sequential Dosing , Single Ascending Dose and Multiple Dose Safety Tolerability and Pharmacokinetic Study | completed | Phase 1 | 48 | Kashiv BioSciences, LLCINDUSTRY | 1 | Oct 10, 2023 | clinicaltrials |
| NCT03625388 | Low Dose Dasatinib (50 mg Daily) as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia | completed | Phase 2 | 56 | Hikma Pharmaceuticals LLCINDUSTRY | 4 | Sep 22, 2023 | clinicaltrials |
| NCT06035614 | Efficacy and Safety of 308-nm Excimer Lamp Combined With Tacrolimus vs Tacrolimus as Monotherapy in Treating Vitiligo on Children | completed | N/A | 50 | ClarteisINDUSTRY | 1 | Sep 13, 2023 | clinicaltrials |
| NCT03626545 | Phase III Study Evaluating Efficacy and Safety of Canakinumab in Combination With Docetaxel in Adult Subjects With Non-small Cell Lung Cancers as a Second or Third Line Therapy(CANOPY-2) | terminated | Phase 3 | 245 | Novartis PharmaceuticalsINDUSTRY | 26 | Aug 21, 2023 | clinicaltrials |
| NCT05836337 | Clinical Trial Evaluating the Effectiveness of a Tattoo Compared to a Clip Applied to Axillary Lymph Nodes in Breast Cancer Patients Who Undergo SLNBx | completed | N/A | 54 | King Hussein Cancer CenterOTHER | 1 | May 1, 2023 | clinicaltrials |
| NCT04731051 | The Potential Use of Inhaled Hydroxychloroquine for the Treatment of COVID-19 in Cancer Patients | withdrawn | Phase 1 / Phase 2 | 0 | King Hussein Cancer CenterOTHER | 1 | Apr 7, 2023 | clinicaltrials |
| NCT03742596 | Effect of Probiotics Supplementation on the Side Effects of Radiation Therapy Among Colorectal Cancer Patients | withdrawn | Phase 2 / Phase 3 | 0 | King Hussein Cancer CenterOTHER | 1 | Mar 15, 2023 | clinicaltrials |
| NCT03447132 | Fulvestrant Versus Fulvestrant Plus Palbociclib in Operable Breast Cancer Responding to Fulvestrant(SAFIA) | completed | Phase 3 | 354 | International Cancer Research Group, United Arab EmiratesOTHER | 8 | Mar 10, 2023 | clinicaltrials |
| NCT03707860 | Radiation Oncology Mobile Application(γ-App) | withdrawn | — | 0 | King Hussein Cancer CenterOTHER | 1 | May 27, 2022 | clinicaltrials |
| NCT05057299 | Extramedullary Acute Myeloid Leukemia (eAML): Retrospective Single Center Cohort Study, Clinicopathological, Molecular Analysis and Survival Outcomes | completed | — | 32 | King Hussein Cancer CenterOTHER | 1 | Sep 27, 2021 | clinicaltrials |
| NCT02092467 | Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis | completed | Phase 4 | 4,372 | PfizerINDUSTRY | 30 | Aug 17, 2021 | clinicaltrials |
| NCT04759638 | Short Running Head Obesity in Rectal Cancer Patients | completed | — | 294 | King Hussein Cancer CenterOTHER | 1 | Feb 18, 2021 | clinicaltrials |
| NCT02788214 | Helicobacter Pylori Genome Project (HpGP) | terminated | — | 1,000 | National Cancer Institute (NCI)NIH | 53 | Dec 19, 2020 | clinicaltrials |
| NCT01947608 | Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC | no longer available | — | — | Novartis PharmaceuticalsINDUSTRY | 10 | Nov 3, 2020 | clinicaltrials |
| NCT04424732 | SBRT for Breast Cancer Oligometastases | unknown | N/A | 50 | King Hussein Cancer CenterOTHER | 1 | Jun 11, 2020 | clinicaltrials |
| NCT04416620 | The Impact of a Pharmaceutical Care Model on Improving Polycystic Ovary Syndrome | completed | N/A | 118 | Applied Science Private UniversityOTHER | 2 | Jun 4, 2020 | clinicaltrials |
| NCT02568943 | An Expanded Treatment Protocol of Panobinostat in Combination Therapy for Relapsed, and Relapsed and Refractory Multiple Myeloma | no longer available | — | — | Novartis PharmaceuticalsINDUSTRY | 6 | Apr 8, 2020 | clinicaltrials |
| NCT03176238 | Study in Post-menopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer(EVEREXES) | completed | Phase 3 | 235 | Novartis PharmaceuticalsINDUSTRY | 13 | Apr 7, 2020 | clinicaltrials |
| NCT03460678 | Randomized Comparative Study of Erlotinib and Pemetrexed in the Maintenance Treatment of Advanced Lung Cancer Patients. | terminated | Phase 4 | 9 | Hikma Pharmaceuticals LLCINDUSTRY | 2 | Mar 5, 2020 | clinicaltrials |
| NCT03348046 | Safety Study of Remsima® (Infliximab) in Rheumatoid Arthritis Patients in Jordan(PASSRRA) | completed | — | 22 | Hikma Pharmaceuticals LLCINDUSTRY | 1 | Mar 4, 2020 | clinicaltrials |
| NCT03066245 | Use of Stem Cells Cultured on a Scaffold for the Treatment of Aneurysmal Bone Cysts (ABC) | unknown | Phase 1 / Phase 2 | 4 | Sophia Al-AdwanOTHER | 1 | Jul 24, 2019 | clinicaltrials |
| NCT01206764 | A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma. | completed | Phase 4 | 143 | Novartis PharmaceuticalsINDUSTRY | 10 | Jun 24, 2019 | clinicaltrials |
| NCT03480230 | Neoadjuvant Compound 121564 Plus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer | unknown | Phase 2 | 60 | Arafat TfayliOTHER | 2 | Aug 14, 2018 | clinicaltrials |
| NCT00777101 | Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer | completed | Phase 2 | 233 | Puma Biotechnology, Inc.INDUSTRY | 31 | Aug 9, 2018 | clinicaltrials |
| NCT01172548 | Safety and Efficacy Evaluation of Two Year Imatinib Treatment in Adjuvant Gastrointestinal Stromal Tumor (GIST)(INV555) | completed | Phase 2 | 132 | Novartis PharmaceuticalsINDUSTRY | 12 | May 31, 2017 | clinicaltrials |
| NCT02977312 | Study of Cemivil® (Imatinib) in Chronic Myeloid Leukemia Patients in Jordan(CCMLJ) | completed | — | 91 | Hikma Pharmaceuticals LLCINDUSTRY | 1 | Nov 30, 2016 | clinicaltrials |
| NCT02328404 | The Effect of Vitamin D Supplementation Among Overweight Jordanian Women With Polycystic Ovary Syndrome (PCOS) | completed | Phase 3 | 60 | Hayat Pharmaceutical Co. PLCINDUSTRY | 1 | Aug 4, 2016 | clinicaltrials |
| NCT02695849 | A Study of Prevalence of EGFR Mutations in Participants With NSCLC | completed | — | 69 | Hoffmann-La RocheINDUSTRY | 1 | Jul 4, 2016 | clinicaltrials |
| NCT02273856 | Multicentre Registry of Treatments and Outcomes in Patients With Chronic Lymphocytic Leukaemia (CLL) Or Indolent Non Hodgkin's Lymphoma (iNHL)(NADIR) | terminated | — | 25 | Astellas Pharma International B.V.INDUSTRY | 7 | Jun 21, 2016 | clinicaltrials |
| NCT02141373 | Effectivenes of Cyanoacrylate (Glubran 2®) in Reducing Seroma Formation in Breast Cancer Patients Post-Axillary Dissection | unknown | N/A | 136 | King Hussein Cancer CenterOTHER | 1 | Apr 3, 2015 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials